NEW ORLEANS, LA—A single subcutaneous injection of a novel, small-molecule glycoprotein IIb/IIIa inhibitor administered at first medical contact in patients with suspected STEMI improves the patency ...

LONDON, Sept. 4, 2025 /PRNewswire/ -- World Finance Magazine has named iib East Africa the Most Sustainable Bank in Djibouti for 2025 within its annual banking awards. Part of the Intercontinental ...

LONDON, Sept. 4, 2025 /PRNewswire/ -- World Finance Magazine has named iib East Africa the Most Sustainable Bank in Djibouti for 2025 within its annual banking awards. These include financing ...

LONDON, United Kingdom, July 19, 2025 (EZ Newswire) -- iib East Africa, opens new tab has earned international recognition for its leadership in sustainable banking, securing three prestigious awards ...

"Prof. Valmed", an AI-supported chatbot for the medical sector, is the first class IIb medical language AI to receive approval. The system uses a large language model to search for specific validated ...

AP Inter 2nd Year Mathematics Paper- IIB Exam 2025: Candidates can find the AP Inter 2nd Year Mathematics Paper- IIB question paper and answer key on this page. The question paper serves as a valuable ...

The phase IIb study results of Supernus Pharmaceuticals Inc.’s SPN-820 in treatment-resistant depression had pulled the company’s stock (NASDAQ:SUPN) down 15.6% on Feb. 19. The randomized, ...

The US Food and Drug Administration (FDA) has granted approval for Zydus Lifesciences to proceed with a randomised Phase IIb trial of its oral NLRP3 inflammasome inhibitor, Usnoflast, for amyotrophic ...

If you’re completely new to Microsoft Word, you’re probably wondering where to begin. You’ve come to the right place because we’ll get you started. From what you see in the Word window to how to save ...

ISKANDAR PUTERI: Iskandar Investment Bhd (IIB), the master developer of Iskandar Puteri, via River Retreat Sdn Bhd, has entered into a strategic partnership with TM-Nxera that will entail an ...

Aerovate Therapeutics Inc. is shutting down the ongoing phase III portion of its Impahct study of AV-101, an inhaled version of PDGFR inhibitor imatinib, after reporting top-line data from the phase ...